FDA

AZ
Content Channel

FDA delays ruling on AstraZeneca drug after negative adcomm vote

The FDA deferred its ruling on AstraZeneca’s camizestrant to review analyses filed after an advisory committee voted against the breast cancer asset.
Nick Paul Taylor May 27, 2026 4:43am
Open door symbolizing exit
Favicon Fierce Pharma

CDER chief Høeg and CBER's Szarama exiting FDA posts

May 15, 2026 1:44pm
Aardvark

Aardvark to dig into phase 3 data early after FDA imposes hold

May 15, 2026 1:51am
FDA
Favicon Fierce Pharma

Biopharma rallies behind Pazdur to lead FDA. But is he willing?

May 14, 2026 11:05am
Warren Biddle

Kyverna begins rolling FDA submission for autoimmune CAR-T in SPS

May 12, 2026 4:27pm
Martin Makary FDA Senate HELP confirmation
Favicon Fierce Pharma

FDA's embattled Marty Makary steps down as commissioner

May 12, 2026 2:30pm